Incruse Ellipta and Kisqali Femara Co-Pack 400 mg-2.5 mg Dose
Determining the interaction of Incruse Ellipta and Kisqali Femara Co-Pack 400 mg-2.5 mg Dose and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: umeclidinium
Brand name: Incruse Ellipta
Synonyms: n.a.
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: Kisqali Femara Co-Pack 200 mg-2.5 mg Dose, Kisqali Femara Co-Pack
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Incruse Ellipta-Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
- Incruse Ellipta-Kitabis Pak
- Incruse Ellipta-Kitabis Pak inhalation
- Incruse Ellipta-Klofensaid II
- Incruse Ellipta-Klonopin
- Incruse Ellipta-Klonopin Wafer
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Indacaterol
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Indacaterol and Glycopyrrolate
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Indacaterol and glycopyrrolate Inhalation
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Indacaterol inhalation
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Indacaterol Maleate
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Indapamide